Literature DB >> 7041149

Late side effects related to inflatable breast prostheses containing soluble steroids.

R M Oneal, L C Argenta.   

Abstract

Long-term follow-up of 12 patients who have undergone augmentation mammaplasty with breast prostheses containing 62.5 mg of methylprednisolone hemisuccinate is presented. Significant complications, including prosthesis ptosis, atrophy and thinning of overlying breast tissue, impending extrusion, and capsular contracture are discussed. Excellent results can be followed by significant complications many years later. Many of these changes are reversible when steroid-containing prostheses are exchanged for new nonsteroid prostheses. Long-term follow-up of patients who have undergone augmentation mammaplasty with prostheses containing steroids is recommended.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041149     DOI: 10.1097/00006534-198204000-00012

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  3 in total

Review 1.  Absence of capsular contracture in 319 consecutive augmentation mammaplasties: Dependent drains as a possible factor.

Authors:  Nabil Fanous; Iman Salem; Carolyne Tawilé; Ae Bassas
Journal:  Can J Plast Surg       Date:  2004

2.  Another look at steroids: intraluminal methylprednisolone in retropectoral augmentation mammoplasty.

Authors:  M P Ceravolo; A del Vescovo
Journal:  Aesthetic Plast Surg       Date:  1993       Impact factor: 2.326

3.  Breast augmentation: a review of subglandular and submuscular implantation.

Authors:  B Vazquez; K S Given; G C Houston
Journal:  Aesthetic Plast Surg       Date:  1987       Impact factor: 2.326

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.